about
Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake.Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.Enhanced antioxidation via encapsulation of isooctyl p-methoxycinnamate with sodium deoxycholate-mediated liposome endocytosis.Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: preparation by supercritical fluid technology and evaluation in vitro and in vivoChitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLDCD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory SkinNanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolinTransdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gelEnhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomesEthyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticlesMucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridoninCurcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapyXiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of CajalActivation of a gamma-cyclodextrin-based metal-organic framework using supercritical carbon dioxide for high-efficient delivery of honokiolRecent progress in the synthesis, structural diversity and emerging applications of cyclodextrin-based metal-organic frameworksNovel nanostructured lipid carriers-loaded dissolving microneedles for controlled local administration of aconitineMesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug deliveryNaringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia EffectsIncreased microneedle-mediated transdermal delivery of tetramethylpyrazine to the brain, combined with borneol and iontophoresis, for MCAO preventionFunctional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transportImproved self-assembled micelles based on supercritical fluid technology as a novel oral delivery system for enhancing germacrone oral bioavailabilityRed blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor applicationConstruction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6Exploring the Potential of Mesoporous Silica as a Carrier for Puerarin: Characterization, Physical Stability, and In Vivo PharmacokineticsHybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancerAn herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine/nitric oxide pathway: A metabolomics-based systematic studyDOC-LS, a new liposome for dermal delivery, and its endocytosis by HaCaT and CCC-ESF-1 cellsFunctional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis
P50
Q38935183-54582EBE-A30B-45A3-86E4-9B47D5C59F2DQ47699100-4E798975-F2E3-40D8-AE46-3B096FAF2556Q52664403-512E57D9-1301-42C1-AA28-AE98A40AC48AQ57186885-1A6CF315-D803-4D7B-9342-0947D729CA89Q58765669-3328A204-D210-4670-B4F6-8B4725D360F2Q60923343-2F674BCC-E097-4613-9710-1003E37FE151Q85675243-44F5D4B0-5E2F-49F1-B01B-E7AA95EBFA37Q86412611-22544B0C-ECBF-410B-9FDE-0BC9AA15791BQ86833321-B2A36E18-AD08-41F1-A162-581C92221C98Q87811658-8582967F-CC11-45A2-8A8D-18C29128B0F6Q88139046-F9CDBC6F-A6CB-4B98-8A6B-1FFDB2F4F916Q88782620-8BC8B426-E4FC-4D0E-AC30-16D1FDA13A4BQ89964134-C74DC945-DF80-40EE-B460-15D7BF92B11BQ89981054-0F551A51-5C50-40A9-90F6-89CB3ED3A076Q90139342-BCE93A59-8B83-49A9-91B2-D9B7ED13B5B1Q91205708-C75EAFC9-AE9D-4416-B4C0-409EF16386F2Q91239741-018054CA-BCAA-4F18-92A2-D93FE5FC23A9Q91638353-AA6394AE-4DE6-4ECD-A6AC-A54256398532Q92130282-C7C2DF37-E696-43E0-8434-BF15408044AAQ92387387-23676AC3-B646-4B0A-BAD8-00525F77FAD2Q92387553-8C976016-AAF3-4670-8CB9-0D2081AE81D6Q92435681-3E542C48-B4C3-4259-B6CE-5BDDC6C8827AQ92500086-B497D08F-5873-4AF6-A601-5A330E8DC9E2Q92631252-4B534840-BE89-425B-A586-2ED9BF1D72EFQ92696436-7DBFE032-C73F-4AF2-8ED9-5042DEB2BFF3Q92938417-FCF83CEE-A57A-48C8-ABD6-D23C7A258A12Q92964299-898DAA4A-3309-4C6D-95CE-CD9E9683CD07Q96028900-D50356C9-79E6-44CD-B713-5613BE05FA18
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nianping Feng
@ast
Nianping Feng
@en
Nianping Feng
@es
Nianping Feng
@nl
type
label
Nianping Feng
@ast
Nianping Feng
@en
Nianping Feng
@es
Nianping Feng
@nl
prefLabel
Nianping Feng
@ast
Nianping Feng
@en
Nianping Feng
@es
Nianping Feng
@nl
P106
P31
P496
0000-0002-5303-2941